Newsfeeds Archive - Page 4 of 4

2 minute read

News

Intuity Medical And Embecta Launch Commercial Collaboration, Expanding Access To Self-management Innovations For People With Diabetes

November 7, 7:53 AM

Intuity Medical, Inc. and Embecta Corp. (“embecta”) (NASDAQ:EMBC) today announced they have signed a co-promotional agreement under which embecta sales representatives will be able to promote Intuity

EMBC

9 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For September 8, 2022

By Benzinga Insights

September 8, 10:15 AM

ALBO

1 minute read

BTIG Initiates Coverage On Embecta with Neutral Rating

By Benzinga Newsdesk

September 8, 8:14 AM

BTIG analyst Marie Thibault initiates coverage on Embecta (NASDAQ:EMBC) with a Neutral rating.

EMBC

1 minute read

Dividends

Embecta’s Ex-Dividend Date Is Thursday, Here’s What You Need To Know

By Benzinga Insights

August 22, 10:49 AM

Wednesday marks the last chance for investors to receive the next dividend payout from Embecta (NASDAQ:EMBC).

EMBC

1 minute read

Morgan Stanley Maintains Equal-Weight on Embecta, Raises Price Target to $36

By Benzinga Newsdesk

August 16, 7:51 AM

Morgan Stanley analyst Cecilia Furlong maintains Embecta (NASDAQ:EMBC) with a Equal-Weight and raises the price target from $33 to $36.

EMBC

7 minute read

This Financial Services Stock Surged Around 116%; Here Are 86 Biggest Movers From Yesterday

By Lisa Levin

August 16, 3:28 AM

Gainers Magic Empire Global Limited (NASDAQ: MEGL) shares jumped 115.7% to close at $17.73 on volatility following the company's IPO earlier this month.

AGFY

5 minute read

Why Viridian Therapeutics Is Trading Higher By Around 58%, Here Are 67 Stocks Moving In Monday’s Mid-Day Session

By Lisa Levin

August 15, 12:05 PM

Gainers Sunrise New Energy Co. Ltd. (NASDAQ: EPOW) shares jumped 118.2% to $4.4948. Sunrise New Energy said that the company changed its name from Global Internet of the People, Inc. to Sunrise New Energy effective as of August 10, 2022.

APRN

1 minute read

Embecta Q3 EPS $1.07 Beats $0.87 Estimate, Sales $291.10M Beat $276.86M Estimate

By Benzinga Newsdesk

August 15, 6:32 AM

Embecta (NASDAQ:EMBC) reported quarterly earnings of $1.07 per share which beat the analyst consensus estimate of $0.87 by 22.99 percent. The company reported quarterly sales of $291.10 million which beat the analyst

EMBC